Cargando…
Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe and progressive muscle-wasting disorder caused by mutations in the dystrophin gene that result in the absence of the membrane-stabilising protein dystrophin. Dystrophic muscle fibres are susceptible to injury and degeneration, and impaired mu...
Autores principales: | Swiderski, Kristy, Todorov, Michelle, Gehrig, Stefan M, Naim, Timur, Chee, Annabel, Stapleton, David I, Koopman, René, Lynch, Gordon S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909382/ https://www.ncbi.nlm.nih.gov/pubmed/24476069 http://dx.doi.org/10.1186/1755-1536-7-1 |
Ejemplares similares
-
Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice
por: Stapleton, David I., et al.
Publicado: (2014) -
Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in mdx Dystrophic Mice
por: Swiderski, Kristy, et al.
Publicado: (2021) -
Spatiotemporal Mapping Reveals Regional Gastrointestinal Dysfunction in mdx Dystrophic Mice Ameliorated by Oral L-arginine Supplementation
por: Swiderski, Kristy, et al.
Publicado: (2020) -
Muscle-specific deletion of SOCS3 increases the early inflammatory response but does not affect regeneration after myotoxic injury
por: Swiderski, Kristy, et al.
Publicado: (2016) -
Deletion of suppressor of cytokine signaling 3 (SOCS3) in muscle stem cells does not alter muscle regeneration in mice after injury
por: Swiderski, Kristy, et al.
Publicado: (2019)